Myopericytoma arising from myopericytosis-a hitherto unrecognized entity within the lung.

Ulrike Gruber-Moesenbacher, Alicia Morresi-Hauff, Katja Behr, Helmut Popper

Open access · hybridAbstract readCase Reports

In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.2field-weighted citation impact, top 43% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Ulrike Gruber-MoesenbacherInstitute of Pathology, Helios Clinics, Gauting, Germany.

Alicia Morresi-HauffInstitute of Pathology, Helios Clinics, Gauting, Germany.

Katja BehrInstitute of Pathology, Mittelthueringen, Bad Berka, Germany.

Helmut PopperInstitute of Pathology, Medical University of Graz, Neue Stiftingtalstrasse 6, 8036, Graz, Austria. helmut.popper@medunigraz.at.ORCID http://orcid.org/0000-0003-4970-1265

Asklepios Fachkliniken München-Gauting · DEMedical University of Graz · ATZentralklinik Bad Berka · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two cases of myopericytosis combined with pericytoma originating within the lung are reported. These are rare pulmonary tumors. The differential diagnosis for hemangiopericytoma and pericytic tumors with glomus elements is discussed. Both myopericytic lesions mimic other lesions, which are more commonly seen in the lung. Based on the expression of vascular growth factor receptors 2 and 3, an antiangiogenic therapy was suggested for the patient with the myopericytoma. A treatment with an angiogenesis inhibitor resulted in a regression of the tumor, but not the precursor lesion. Probably a more specific therapy using tyrosine kinase inhibitors for VEGFR2/3 might better control these myopericytic proliferations.

Indexed as

AdultAged, 80 and overAngiogenesis InhibitorsBiomarkers, TumorFemaleHumansLungLung NeoplasmsMyopericytomaPericytesPrecancerous ConditionsTreatment OutcomeVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor Receptor-3Angiogenesis InhibitorsBiomarkers, TumorFLT4 protein, humanKDR protein, humanVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor Receptor-3LungMyopericytomaMyopericytosisPericytic tumor

Identifiers

PMID33244708

DOI10.1002/1097-0142(19870201)59:3<549::AID-CNCR2820590332>3.0.CO;2-Y

PMCPMC8099806

OpenAlexW3110121688

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.